Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Jeffrey R. Curtis
University of Alabama at Birmingham, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
GlaxoSmithKline
Payment for services (e.g., consulting fees, honoraria, paid authorship)
The outcome of the research is of significant business interest to the entity and therefore the financial interest could likely change based on the research results.
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Results from this trial are expected to change clinical practice by demonstrating both short and longer-term effectiveness, as well as safety and tolerability, of the live zoster vaccine among current anti-TNF users. Rheumatologists and other providers will be able to improve the care, outcomes, and quality of life for patients on these biologies, substantially decreasing the morbidity of herpes zoster and its complications over a lifetime.
Filed on January 29, 2015.
Tell us what you know about Jeffrey R. Curtis's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Jeffrey R. Curtis”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Jeffrey R. Curtis | University of Alabama at Birmingham | Conflict of Interest | Pfizer | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.